Inventor · disambiguated record
Zhenhua Miao
Also filed as: MIAO ZHENHUA
21 granted patents·13 pending applications·109 citations·filing 2000–2024
94Inventor score
Top patents by PatentIndex Score
34 records- 0192US11382915B2Treatment of focal segmental glomerulosclerosis with CCR2 antagonistsCHEMOCENTRYX INC·Filed 2020·Granted Jul 12, 2022·2 cites·20 claims
- 0291US11324736B2Method of Treating Focal Segmental GlomerulosclerosisCHEMOCENTRYX INC·Filed 2020·Granted May 10, 2022·2 cites·23 claims
- 0390US11304952B2Combination therapy using a chemokine receptor 2 (CCR2) antagonist and a PD-1/PD-L1 inhibitorCHEMOCENTRYX INC·Filed 2018·Granted Apr 19, 2022·11 cites·16 claims
- 0490US6699677B1Tethered ligands and methods of useCHEMOCENTRYX INC·Filed 2000·Granted Mar 2, 2004·31 cites·37 claims
- 0588US7396653B2Cell migration assayCHEMOCENTRYX INC·Filed 2007·Granted Jul 8, 2008·10 cites·22 claims
- 0686US10973809B2Method of treating focal segmental glomerulosclerosisCHEMOCENTRYX INC·Filed 2017·Granted Apr 13, 2021·4 cites·15 claims
- 0786US10758540B2Treatment of focal segmental glomerulosclerosis with CCR2 antagonistsCHEMOCENTRYX INC·Filed 2018·Granted Sep 1, 2020·4 cites·26 claims
- 0886US6998239B1Method for identifying a modulator of the binding of CCX CKR polypeptide to a chemokineCHEMOCENTRYX INC·Filed 2000·Granted Feb 14, 2006·12 cites·17 claims
- 0981US10682344B2Method of treating liver fibrosisCHEMOCENTRYX INC·Filed 2017·Granted Jun 16, 2020·2 cites·20 claims
- 1081US7282338B2Cell migration assayCHEMOCENTRYX INC·Filed 2002·Granted Oct 16, 2007·15 cites·16 claims
- 1180US2024285593A1Combination therapy using a chemokine receptor 2 (ccr2) antagonist and a pd-1/pd-l1 inhibitorCHEMOCENTRYX INC·Filed 2024·Application pending·0 cites
- 1277US7572600B2Enzymatic activities in chemokine-mediated inflammationCHEMOCENTRYX INC·Filed 2005·Granted Aug 11, 2009·3 cites·10 claims
- 1376US12194032B2Method of treating focal segmental glomerulosclerosisCHEMOCENTRYX INC·Filed 2022·Granted Jan 14, 2025·0 cites·20 claims
- 1476US2023263784A1Combination therapy using a chemokine receptor 2 (ccr2) antagonist and a pd-1/pd-l1 inhibitorCHEMOCENTRYX INC·Filed 2023·Application pending·0 cites
- 1574US2022313668A1Method of treating liver fibrosisCHEMOCENTRYX INC·Filed 2022·Application pending·0 cites
- 1672US2022296601A1Treatment of focal segmental glomerulosclerosis with ccr2 antagonistsCHEMOCENTRYX INC·Filed 2022·Application pending·0 cites
- 1770US7442512B2Compositions and methods for detecting and treating diseases and conditions related to chemokine receptorsCHEMOCENTRYX INC·Filed 2002·Granted Oct 28, 2008·5 cites·22 claims
- 1869US6835547B1Methods for identifying modulators of CCX CKR activityCHEMOCENTRYX INC·Filed 2000·Granted Dec 28, 2004·7 cites·34 claims
- 1968US11357760B2Method of treating liver fibrosisCHEMOCENTRYX INC·Filed 2020·Granted Jun 14, 2022·0 cites·20 claims
- 2066US2023023075A1Combination therapy using a chemokine receptor 2 (ccr2) antagonist and a pd-1/pd-l1 inhibitorCHEMOCENTRYX INC·Filed 2022·Application pending·0 cites
- 2163US2019275015A1Combination therapy using a chemokine receptor 2 (ccr2) antagonist and a pd-1/pd-l1 inhibitorCHEMOCENTRYX INC·Filed 2019·Application pending·0 cites
- 2262US7871619B2Compositions and methods for detecting and treating diseases and conditions related to chemokine receptorsCHEMOCENTRYX INC·Filed 2004·Granted Jan 18, 2011·1 cites·10 claims
- 2361US7108990B2Chemokine receptorCHEMOCENTRYX INC·Filed 2004·Granted Sep 19, 2006·0 cites·14 claims
- 2454US2003215460A1Methods and compositions for inducing an immune responseFiled 2002·Application pending·0 cites
- 2550US2005239130A1Method for identifying a modulator of the binding of CCX CKR polypeptide to a chemokineCHEMOCENTRYX INC·Filed 2005·Application pending·0 cites
- 2650US2010247540A1Methods and Compositions For Modulating AngiogenesisCHEMOCENTRYX INC·Filed 2009·Application pending·0 cites
- 2750US2005186556A1Cell migration assayCHEMOCENTRYX·Filed 2005·Application pending·0 cites
- 2849US7413866B2Compositions and methods for detecting and treating diseases and conditions related to chemokine receptorsCHEMOCENTRYX INC·Filed 2003·Granted Aug 19, 2008·0 cites·2 claims
- 2946US8637043B2Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereofSCHALL THOMAS J·Filed 2005·Granted Jan 28, 2014·0 cites·11 claims
- 3046USRE39849EMethods for identifying modulators of CCX CKR activityCHEMOCENTRYX INC·Filed 2005·Granted Sep 18, 2007·0 cites·34 claims
- 3143US2011165164A1Compositions and methods for detecting and treating diseases and conditions related to chemokine receptorsCHEMOCENTRYX INC·Filed 2010·Application pending·0 cites
- 3241US8088895B2Antibodies that bind CXCR7 epitopesPREMACK BRETT·Filed 2007·Granted Jan 3, 2012·0 cites·12 claims
- 3340US2003096260A1Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereofFiled 2002·Application pending·0 cites
- 3439US2005214287A1Methods and compositions for modulating angiogenesisCHEMOCENTRYX INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zhenhua Miao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →